Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02RNS
|
|||
| Former ID |
DIB005391
|
|||
| Drug Name |
Oglufanide
|
|||
| Synonyms |
Glufanide disodium; Oglufanide disodium; IM-862; Kaposis sarcoma therapy, Cytran
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Bacterial infection [ICD-11: 1A00-1C4Z; ICD-10: A00-B99] | Phase 3 | [1] | |
| Company |
Cytran Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H19N3O5
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N
|
|||
| InChI |
1S/C16H19N3O5/c17-11(5-6-14(20)21)15(22)19-13(16(23)24)7-9-8-18-12-4-2-1-3-10(9)12/h1-4,8,11,13,18H,5-7,17H2,(H,19,22)(H,20,21)(H,23,24)/t11-,13-/m0/s1
|
|||
| InChIKey |
LLEUXCDZPQOJMY-AAEUAGOBSA-N
|
|||
| CAS Number |
CAS 38101-59-6
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:73512
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00002445) Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.